Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Completed · Not applicable · Has a placebo group
Conditions studied: Obesity
In brief
The overall goal of this proposal is to evaluate the efficacy of transcranial direct current stimulation (tDCS), a noninvasive neuromodulation technique, to facilitate weight loss and weight loss maintenance in obesity. This is a novel clinical research study that examines the therapeutic potential of an innovative biomedical treatment for weight loss.
Key facts
- Study ID
- NCT02953353
- Run by
- University of Sao Paulo
- People needed
- 38
- Starts
- 2017-06-12
- Expected to finish
- 2019-03-29
- Last updated by the study team
- 2021-01-22
Who can join
Age: 20 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women with obesity (BMI 30-35 kg/m2), with stable weight over the previous 3 months.
You may not qualify if…
- pregnancy
- diabetes
- acute and chronic kidney disease
- pancreatitis
- any active psychiatric or neurological condition at the time of joining the study
- intake of centrally-acting medications that could interfere with tDCS effects
- anemia (Hgb <12 g/dl)
- any other significant medical condition
- contraindications for tDCS, which includes damaged skin at the site of stimulation, any electrically sensitive or metallic device and history of epilepsy
Where it is running
- Human Nutrition Research Center on Aging, Tufts University — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Harvard Medical School — Boston, Massachusetts, United States
- Clinical Hospital of Ribeirão Preto — Ribeirão Preto, São Paulo, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.